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Abstract
3-O-Methylfluorescein phosphate hydrolysis, catalyzed by purified erythrocyte Ca2-ATPase in the absence of Ca2, was
slow in the basal state, activated by phosphatidylserine and controlled proteolysis, but not by calmodulin. p-Nitrophenyl
phosphate competitively inhibits hydrolysis in the absence of Ca2, while ATP inhibits it with a complex kinetics showing a
high and a low affinity site for ATP. Labeling with fluorescein isothiocyanate impairs the high affinity binding of ATP, but
does not appreciably modify the binding of any of the pseudosubstrates. In the presence of calmodulin, an increase in the
Ca2 concentration produces a bell-shaped curve with a maximum at 50 WM Ca2. At optimal Ca2 concentration,
hydrolysis of 3-O-methylfluorescein phosphate proceeds in the presence of fluorescein isothiocyanate, is competitively
inhibited by p-nitrophenyl phosphate and, in contrast to the result observed in the absence of Ca2, it is activated by
calmodulin. In marked contrast with other pseudosubstrates, hydrolysis of 3-O-methylfluorescein phosphate supports Ca2
transport. This highly specific activity can be used as a continuous fluorescent marker or as a tool to evaluate partial steps
from the reaction cycle of plasma membrane Ca2-ATPases. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The plasmalemmal Ca2-ATPase of mammalian
erythrocytes (PMCA) is a P-type ATPase responsible
for the maintenance of the low intracellular Ca2
concentrations critical for cell survival and for the
second messenger role of Ca2. During the catalytic
cycle, the enzyme alternates through two major con-
formers, namely E1 and E2 ([1^4]; see [5,6] for recent
reviews). E1 has a high a⁄nity for Ca2 and is read-
ily phosphorylated by ATP, while E2 has a low af-
¢nity for Ca2 and can be phosphorylated by Pi (see
Scheme 1). Addition of calmodulin (CaM) [7^10],
phosphatidylserine (PS) [11^13], dimethyl sulfoxide
up to 10% [12,14,15], and controlled tryptic cleavage
[16^18] dislocate internal self-inhibitory peptides and
increase the maximal velocity of ATP hydrolysis, as
well as the a⁄nity of the enzyme for Ca2. The en-
zyme has a high speci¢city for the substrate to be
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hydrolyzed, since GTP, ITP, UTP and CTP are in-
e¡ective substrates for the nucleotide triphosphatase
and Ca2 transporting activities [19,20]. The hydro-
lytic cycle and the catalytic site have been character-
ized using ATP and/or p-nitrophenyl phosphate
(pNPP) as substrates [1^6].
The enzyme hydrolyzes ATP through the entire
E1^E2 cycle coupled to the transport of one Ca2
molecule to the outside of the cell [1^6,21], while
pNPP appears to be hydrolyzed exclusively by the
E2 conformation [16,22,23], except in a medium con-
taining dimethyl sulfoxide [14]. ATP is not hydro-
lyzed by the E2 conformer. Diisothiocyanatostil-
bene-2,2P-disulfonic acid (DIDS) activates pNPP
hydrolysis and simultaneously inhibits ATPase activ-
ity [24] proposedly by driving the enzyme towards an
‘E2-like’ conformation. The molecular reasons for
such mechanisms and, more speci¢cally, the possible
modi¢cations of the catalytic site during E1^E2 tran-
sitions are unclear.
Here we investigate the hydrolysis of 3-O-methyl-
£uorescein phosphate (3-OMFP), a £uorescein deriv-
ative morphologically similar to ATP, by the erythro-
cyte membrane Ca2-ATPase. Due to its similarity
with ATP and its strong £uorescent properties, this
pseudosubstrate has been proven to be a powerful
tool for the characterization of the catalytic cycle of
several enzymes including alkaline phosphatases [25],
the cell cycle regulator protein tyrosine phosphatase
Cdc25 [26], and the two closely related P-type ATP-
ases: the sarcoplasmic reticulum Ca2-ATPase [27^29]
and the (Na+K)-ATPase [30^32]. The Km of
(Na+K)-ATPase for 3-OMFP is two orders of mag-
nitude lower than that for pNPP and the Vmax is two
times greater [30,31], a result similar to that observed
using 3-OMFP as a substrate for Cdc25B [26]. It
is accepted that (Na+K)-ATPase hydrolyzes 3-
OMFP exclusively by the E2 conformer, although
there is indirect evidence that this substrate forms a
phosphorylated intermediate [32]. Hydrolysis of 3-
OMFP by sarcoplasmic reticulum membranes is acti-
vated by Ca2 and is, thus, supposed to occur through
the entire E1^E2 cycle. Both the K-dependent and the
Ca2-activated 3-OMFPase activities have also been
largely used as a reliable method to quantify the
amounts of either (Na+K)-ATPase or sarcoplasmic
reticulum Ca2-ATPase in crude homogenates of sev-
eral tissues, under a variety of physiological and
pathological conditions [33^38]. Here we describe a
strong 3-OMFPase activity catalyzed by puri¢ed
PMCA, that is activated by CaM, PS, tryptic cleavage
and low Ca2 concentrations, inhibited by medium
Ca2 concentrations, and may be used to characterize
PMCA in tissues. This pseudosubstrate supports Ca2
transport and is proposed to undergo the entire cycle
in the presence of Ca2, while it is hydrolyzed by the
E2 conformations in the absence of Ca2.
2. Materials and methods
2.1. Red cell ghosts preparations
Calmodulin-depleted red cell ghost membranes
were prepared from fresh pig blood, lysed isotoni-
cally by freezing at 370‡C followed by thawing, as
described previously by Rega et al. [39]. The protein
concentration of ghost membranes was determined
according to Lowry et al. [40].
2.2. Ca2+-ATPase puri¢cation
The plasma membrane Ca2-ATPase was puri¢ed
from polydocanol-solubilized ghost membranes by
elution through a CaM-Sepharose a⁄nity column
[41], with minor modi¢cations by Pasa et al. [42],
and stored in liquid nitrogen at a concentration of
100^200 Wg ml31 in a medium composed of 20 mM
HEPES (pH 7.4), 0.6 M sucrose, 0.5 M KCl, 0.05%
(v/v) polydocanol, 5 mM MgCl2, 2 mM EDTA, 50
WM CaCl2, 2 mM dithioerythritol, and 0.25 mg ml31
phosphatidylcholine (storage medium). The concen-
tration of the puri¢ed Ca2-ATPase was determined
after precipitation with deoxycholate and TCA [43].
On SDS^PAGE [44], silver staining [45] of this prep-
aration reveals a single band at 135^145 kDa. Puri-
¢ed enzyme displays a speci¢c calmodulin-activated
ATP hydrolysis that varies from 1 to 2 Wmol Pi mg31
min31 at 37‡C, under standard conditions (see be-
low), in the presence of 4 Wg ml31 CaM and 10
WM free Ca2.
2.3. Enzyme labeling with £uorescein isothiocyanate
(FITC)
4 mg ml31 of ghosts were labeled by incubation
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for 40 min at 37‡C, in medium containing 10 WM
FITC (in dimethyl sulfoxide, ¢nal concentration of
10% v/v) and 100 mM Tris^HCl pH 7.4. The reac-
tion was stopped by three 10 min centrifugations at
20 000 rpm in a RPR-12 Hitachi rotor, followed by
washing and resuspension in the same bu¡ered me-
dium but without added FITC. The Ca2-ATPase
after labeling with FITC was puri¢ed and stored as
described above, except that 2 mM lysine was added
to the solubilization medium.
2.4. Determination of hydrolytic activities
The 3-OMFPase activity was assessed £uorimetri-
cally, at room temperature, by following the release
of the product, 3-O-methyl£uorescein (3-OMF), by
the increase in £uorescence emission at 515 nm with
the excitation wavelength set at 475 nm. The stan-
dard medium was 30 mM HEPES (pH 7.4), 120 mM
KCl, 5.5 mM MgCl2, 0.2 mM ethylene glycol-
bis(L-aminoethyl ether)-N,N,NP,NP-tetraacetic acid
(EGTA), 1 Wg ml31 puri¢ed Ca2-ATPase, and 50
WM 3-OMFP as substrate, in the presence or absence
of 4 Wg ml31 CaM, unless otherwise speci¢ed. For
the experiments in the presence of ATP or pNPP,
200 or 400 WM 3-OMFP was used as substrate. Small
volumes of concentrated CaCl2 solutions were added
to result in the desired ¢nal free Ca2 concentration,
calculated according to Fabiato and Fabiato [46]
with the Ca-EGTA constants of Schwarzenbach et
al. [47]. The absence of precipitates from 3-OMFP
and Ca were assured by mixing 3-OMFP and in-
creasing concentrations, up to 3 mM [45Ca]CaCl2,
following ¢ltration through 0.45 Wm pore size Milli-
pore ¢lters. No precipitates were observed in the ¢l-
ters.
pNPP hydrolysis was measured in a medium sim-
ilar to that used for measuring the 3-OMFPase, ex-
cept that 3-OMFP was omitted and reactions were
started by the addition of pNPP to a ¢nal concen-
tration of 13 mM. Puri¢ed enzyme was 2 Wg ml31.
Release of pNPP was detected spectrophotometri-
cally at 425 nm.
For measurements of ATP hydrolysis, enzyme was
incubated at 37‡C in the standard reaction medium
in the absence of 3-OMFP. The reactions were
initiated by addition of either 1 mM or 5 WM
[Q-32P]ATP and stopped by trapping the nucleotide
on charcoal suspended in 0.1 N HCl. The [32P]Pi
released was measured in the supernatant after cen-
trifugation [48].
2.5. Trypsin digestion of the puri¢ed Ca2+-ATPase
Puri¢ed Ca2-ATPase was proteolyzed at 37‡C
with a 1:5 trypsin^protein ratio, essentially as de-
scribed by Zurini et al. [49]. Soybean inhibitor was
added after 6 min in order to stop proteolysis.
2.6. Preparation of erythrocyte inside-out plasma
membrane vesicles and determination of Ca2+
uptake
Inside-out vesicles were prepared as described by
Sarkadi et al. [50]. The resealed plasma membrane
was resuspended in 2.5 mM HEPES^Tris (pH 7.4) at
5 mg ml31. Inside-out vesicles were used on the same
day [51].
The [45Ca]Ca2 uptake was measured by incubat-
ing 0.125 mg inside-out vesicles at 37‡C in 0.6 ml of
uptake bu¡er containing 30 mM HEPES^Tris (pH
7.4), 120 mM KCl, 5.5 mM MgCl2, 0.2 mM EGTA,
4 Wg ml31 CaM, [45Ca]Ca2 (2U106 cpm ml31) and
CaCl2 to give 50 WM free Ca2. The reaction was
started by addition of 400 WM 3-OMFP and stopped
by ¢ltration through 0.45 Wm pore size Millipore
¢lters. Filters were immediately washed three times
with 5 ml of 30 mM Tris^HCl (pH 7.4) containing
2 mM La(NO3)3 and 120 mM KCl. The radioactivity
remaining on the ¢lters was counted in a liquid scin-
tillation counter.
3. Results
Puri¢ed erythrocyte Ca2-ATPase displayed a 3-
OMFPase activity that was increased up to 2^3 times
by the addition of CaM (Fig. 1A). The K0:5 for CaM
activation was in the same order of magnitude as
that for activation of ATP or pNPP hydrolysis, in-
dicating that the binding of the £uorescent substrate
did not modify the binding of CaM.
Hydrolysis of 3-OMFP was regulated by the Ca2
concentration. In an EGTA containing medium, the
E2 conformer catalyzed a slow hydrolysis of the
pseudosubstrate. In the absence of activators (basal
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state), hydrolysis was approximately constant up to
60^70 WM Ca2, and inhibited at higher Ca2 con-
centrations. When CaM was added, a sharp, bell-
shaped curve for Ca2 dependence was observed
with a maximal value at 50 WM Ca2 (Fig. 1B).
Fig. 2 compares the hydrolysis of 3-OMFP with
the hydrolysis of ATP and pNPP. In the presence of
CaM, the enzyme also displays a bell-shaped curve
for Ca2 dependence of both pNPP and ATP hydro-
lysis, although the reasons for activation or inhibi-
tion by Ca2, as well as the values of pCa0:5, are
di¡erent. Puri¢ed enzyme hydrolyzes pNPP at low
velocity by the E2 conformer (triangles in Fig. 2,
and see [14,24]). At such low Ca2 concentrations
(pCa 9.0), neither Ca2 nor CaM binds to the en-
zyme and, thus, we can infer that pNPP is being
hydrolyzed by a nonactivated E2 state of the enzyme,
which, in this paper, we denominated E2:‘basal’ con-
former. As Ca2 is increased (pCa0:5 = 7), Ca2 binds
to CaM, and a complex of CaM with the enzyme
begins to form, eliciting pNPP hydrolysis by the
E2:CaM conformer [16]. At higher Ca2 concentra-
tions (pCa 6 6.5 at pH 7.4), the binding of Ca2
to the enzyme itself promotes the conversion of
E2:CaM to E1:CaM (see [4]). In this range, the p-nitro-
phenylphosphatase activity (triangles) declines and
ATP hydrolysis (squares in Fig. 2) becomes activated
[4^6,16]. On the other hand, puri¢ed enzyme does
not hydrolyze ATP either by the E2:‘basal’ or by the
E2:CaM conformers. The Ca2-ATPase activity is in-
creased when the equilibrium is shifted towards
E1:CaM (squares) and inhibited at pCa 6 4.0 (not
shown), possibly due in part to a competition with
Mg2 and/or because of an inhibition of the release
of Ca2 from the enzyme’s low a⁄nity site following
Ca2 translocation (step 4 in Scheme 1), impairing
enzyme turnover [4^6,13].
Hydrolysis of 3-OMFP by the Ca2-ATPase
(closed circles in Fig. 2) exhibited intermediary char-
acteristics from those exposed by the two substrates
above. As pNPP, the £uorescent substrate was slowly
hydrolyzed through an E2:‘basal’ conformation. Bind-
ing of CaM, eliciting the E2:CaM complex, did not
appear to hydrolyze 3-OMFP as e⁄ciently as it hy-
drolyzed pNPP. A peak of activation was observed
at 50 WM Ca2, suggesting that the E1:CaM conformer
also hydrolyzed 3-OMFP, and did so at velocities
much higher than those observed by the E2 conform-
er in the ‘basal’, nonactivated, state. The pCa0:5 for
Fig. 1. Ca2 and CaM dependence for 3-OMFP hydrolysis by
the erythrocyte Ca2-ATPase. 3-OMFPase activity was deter-
mined in a standard medium as described in Section 2 with 50
WM 3-OMFP and (A) CaCl2 to give 50 WM free Ca2, or (B)
CaCl2 to give the indicated free Ca2 concentrations in the ab-
sence (a) or presence (b) of 4 Wg ml31 CaM. The curves were
normalized for the activities measured in the absence of Ca2,
which were 5.6 and 6.8 Wmol mg31 h31 in the absence and
presence of CaM, respectively. Values are the average þ S.E. of
¢ve normalized experiments with di¡erent preparations.
Scheme 1. Cycle of the plasma membrane Ca2-ATPase.
BBABIO 45114 26-4-02
M.M. Freire et al. / Biochimica et Biophysica Acta 1553 (2002) 238^248 241
activation of 3-OMFP hydrolysis by Ca2 in the
presence of CaM was approximately in the same or-
der of magnitude as that for activation of ATP hy-
drolysis, suggesting conversion of E2:CaM to E1:CaM.
The exact values of pCa0:5 for activation and inacti-
vation of 3-OMFP hydrolysis are di⁄cult to deter-
mine due to the superposition of the activator and
inhibitory e¡ects. The Ca2 concentrations for inac-
tivation of 3-OMFPase activity, however, were
clearly higher than those needed for inactivation of
pNPP hydrolysis (E2:CaM to E1:CaM transition), but
lower than those needed for inactivation of the ATP-
ase activity (Ca2 binding to the low a⁄nity site).
The E2:‘basal’ conformer is inhibited by an endoge-
nous inhibitory peptide situated at the carboxyl-ter-
minus and connected to two receptor peptides situ-
ated at the transduction and at the catalytic cytosolic
domains of the pump [52^54]. The binding of CaM
to the endogenous inhibitory peptide dislocates the
peptide, activating the enzyme. Alternatively, the en-
zyme can be activated by limited proteolysis that
cleaves the inhibitory peptide, deblocking the pump
[18]. Surprisingly, the trypsin treatment elicited an
E2:tryp conformer (at pCa 9.0) that hydrolyzed 3-
OMFP at velocities much higher than those attained
by either the E2:‘basal’ or the E2:CaM conformer (Fig.
3A). When the enzyme was activated by addition of
PS, the E2:PS conformer (in the absence of Ca2, but
presence of PS) also hydrolyzed 3-OMFP at veloc-
ities comparable to those displayed by the E2:tryp con-
former (compare Fig. 3A and B). Addition of Ca2
to the enzyme activated either by PS or by trypsini-
zation caused a small increase in the activities at low
Ca2 concentrations, probably due to the transition
E2 to E1 [55,56], followed by inhibition at medium
Fig. 3. Ca2 dependence for 3-OMFP hydrolysis stimulated by
partial digestion with trypsin or by phosphatidylserine. (A) 3-
OMFPase activity was determined in a standard medium con-
taining 50 WM 3-OMFP, 0.2 mM EGTA and CaCl2 to give the
free Ca2 concentrations as indicated. a, control, non proteo-
lyzed enzyme; b, in the presence of 4 Wg ml31 CaM; 8, en-
zyme treated with trypsin. Partial proteolysis of puri¢ed enzyme
was as described in Section 2. Values are the average þ S.E. of
four experiments with di¡erent preparations. In B, the 3-OMF-
Pase activity was determined as in A, in the absence (a), or in
the presence of 25 (F), 50 (b), or 100 (R) Wg ml31 of phospha-
tidylserine.
Fig. 2. Comparison of the Ca2 dependence for hydrolysis of
3-OMFP with that for hydrolysis of other substrates. The
Ca2 dependences of calmodulin-stimulated 3-OMFPase (b),
pNPPase (R), and ATPase (F) were compared. Substrate con-
centration was 50 WM 3-OMFP, 13 mM pNPP, or 1 mM
[Q32P]ATP. Values are means þ S.E. of three to four experiments
with di¡erent preparations, and were normalized to the maxi-
mum activities measured for each condition, according to Sec-
tion 2.
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Ca2 concentrations (pCa 6 5). The reasons why the
E2:PS and the E2:tryp conformers hydrolyzed 3-OMFP
at velocities higher than the E2:CaM complex are not
clear at this moment. One possibility is that in the
presence of 3-OMFP, CaM binds to E2 but does not
completely dislocate the inhibitory peptide from its
receptor site(s).
Labeling with £uorescein isothiocyanate has been
used as a tool to study events related to the nucleo-
tide binding sites of the Ca2-ATPase. FITC cova-
lently binds to the enzyme at Lys591 [5,57,58], block-
ing ATP binding and hydrolysis [57,58]. In com-
parison with other P-type ATPases (for a review
see [59]), the e¡ects of blocking Lys591 with the £uo-
rescein derivative have been largely less studied in
plasma membrane Ca2-ATPase. In the labeling con-
ditions used in this paper, the Ca2-ATPase lost 90%
of the ATPase activity, but fairly maintained the 3-
OMFPase activity, as well as its dependence on Ca2
and CaM (Fig. 4). In the presence of Ca2 and CaM,
the enzyme displayed a single Km for 3-OMFP. La-
beling with FITC slightly modi¢es the Km (Table 1,
from 130 to 54 WM 3-OMFP, in the absence and
Fig. 5. E¡ect of pNPP on the hydrolysis of 3-OMFP by eryth-
rocyte Ca2-ATPase proteolytically activated. The 3-OMFPase
activity was determined in the standard medium with 50 (a,b),
200 (E,F), or 400 (O,R) WM 3-OMFP, in the absence of
CaCl2, and in the presence of pNPP at the concentrations indi-
cated. Activation by partial proteolysis was as described in Sec-
tion 2. Values are the average þ S.E. of three experiments with
di¡erent preparations. (A) Control; (B) FITC-labeled enzyme.
(Inset) Replots of Ki values from A.
Table 1
Kinetic parameters for 3-OMFP hydrolysis by the plasma mem-
brane Ca2-ATPase
Addition Vmax Km
None 90.1 þ 9.5 138 þ 46
FITC 52.4 þ 1.6 54 þ 8
3-OMFP hydrolysis was measured in a standard medium in the
presence of 50 WM free Ca2 plus 4 Wg ml31 CaM. The values
for Km and Vmax were generated by the best ¢t to the experi-
mental points using a nonlinear regression and considering a
simple Michaelian response to 3-OMFP concentration. The
data are presented as mean þ S.E. of 5^6 experiments with dif-
ferent preparations. Vmax is expressed in micromoles per milli-
gram per hour, Km in micromolar.
Fig. 4. Ca2 dependence for 3-OMFP hydrolysis by FITC-la-
beled erythrocyte Ca2-ATPase. Enzyme was labeled with
FITC as described in Section 2. The 3-OMFPase activity of la-
beled enzyme was determined in a standard medium containing
50 WM 3-OMFP, in the absence (a) or presence (b) of 4 Wg
ml31 CaM. Values are the average þ S.E. of ¢ve experiments
with di¡erent preparations. Curves were normalized for the ac-
tivities measured in the absence of Ca2 which were 3.0 and 3.9
Wmol mg31 h31 in the absence and in the presence of CaM, re-
spectively.
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presence of FITC, respectively). This indicates that
the erythrocyte Ca2-ATPase can support the two
substrate analogues simultaneously bound to the en-
zyme. After labeling, the maximal velocity of 3-
OMFP hydrolysis was reduced by 30^40%, showing
that the inhibition observed in Fig. 4 is due to a
reduction in catalysis.
When the enzyme was activated by controlled
trypsinization and 3-OMFPase activity was mea-
sured in the absence of Ca2, hydrolysis of 3-
OMFP by the E2:tryp conformer is competitively in-
hibited by pNPP with a Ki of 2 mM (Fig. 5A, inset).
Such a⁄nity was in the same range of magnitude of
that already described for the Km for pNPP hydro-
lysis by the ‘E2-activated’ conformer [14], suggesting
that pNPP binds and is hydrolyzed by the ‘E2-acti-
vated’ conformer with similar a⁄nities. Inhibition
was not modi¢ed by labeling with FITC (Fig. 5B).
This behavior is in accordance with those of
(Na+K)-ATPase and SR Ca2-ATPase, in which
binding of FITC does not impair pNPP binding and
hydrolysis [29,59,60].
Hydrolysis of 3-OMFP by the E2:tryp conformer
was also strongly inhibited by ATP (Fig. 6A). The
pattern of inhibition was complex and the inverse
plots curved downwards (not shown). It is notice-
able, however, that, as observed with 3-OMFP and
pNPP as substrate, ATP binds to the E2:tryp conform-
er and does so at, at least, one site of high a⁄nity (in
the Wmolar range, inhibiting 20^30% of the 3-OMF-
Pase activity), and a second site of low a⁄nity. ATP,
however, is not hydrolyzed by the E2 conformer
[5,6,13] (Fig. 2). Labeling with FITC, as expected,
impaired the high a⁄nity binding of ATP to the
enzyme (Fig. 6B). An ATP binding site, with very
low a⁄nity, persists, as previously shown for the
(Na+K)-ATPase [30]. It is interesting to note
that Fig. 6 is evidencing the co-existence of two dis-
tinct binding sites for ATP at the same ‘E2 confor-
mations’, with no need for the enzyme to cycle be-
tween E1 and E2 conformations in order to change
the apparent a⁄nity binding for ATP.
Fig. 7. E¡ect of pNPP on the hydrolysis of 3-OMFP by FITC-
labeled erythrocyte Ca2-ATPase stimulated by Ca2 and CaM.
Enzyme was labeled with FITC as described in Section 2. The
3-OMFPase activity was determined in a standard medium with
CaCl2 to give 50 WM free Ca2, 4 Wg ml31 CaM and 50 (b),
200 (F), or 400 (R) WM 3-OMFP, in the presence of pNPP at
the concentrations indicated. Values are the average þ S.E. of
three experiments with di¡erent preparations.
Fig. 6. E¡ect of ATP on the hydrolysis of 3-OMFP by erythro-
cyte Ca2-ATPase proteolytically activated. Conditions were the
same as for Fig. 5 but ATP was used instead of pNPP. Values
are the average þ S.E. of three experiments with di¡erent prepa-
rations. (A) Control; (B) FITC-labeled enzyme.
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Interestingly, hydrolysis of 3-OMFP at 50 WM
Ca2 (supposedly by the E1 conformer), by a
FITC-labeled enzyme, was also competitively inhib-
ited by pNPP (Fig. 7). The Ki for inhibition was
close (2.7 mM) to that for inhibition of the E2:tryp
conformer (compare Figs. 7 and 5). Our results sug-
gest that 3-OMFP is being hydrolyzed by the same
site at which the enzyme binds pNPP, and hydrolyzes
it solely in the E2 conformation. On the other hand,
3-OMFP is apparently cleaved at this site either by
the E2 conformer or throughout the entire E1^E2
cycle, since, in the conditions of Fig. 7, 3-OMFP is
probably being hydrolyzed by the E1 conformer,
while the high a⁄nity ATP binding site is blocked
by FITC.
In order to verify whether the enzyme, in the pres-
ence of CaM and at 50 WM free Ca2, is in fact
hydrolyzing 3-OMFP throughout the entire cycle,
we measured the capacity for Ca2 uptake. Fig. 8
shows that the enzyme displays a 3-OMFP supported
Ca2 uptake that lasts for at least 90 min. The gra-
dient is completely abolished by addition of the Ca2
ionophore A23587, strongly suggesting that the sub-
strate, or part of the substrate, is hydrolyzed in a
coupled manner cycling across the E1 and E2 con-
formers.
The reasons for the hydrolysis of 3-OMFP (but
not ATP) to be abruptly inhibited at concentrations
higher than 50 WM Ca2 are not clear at this mo-
ment. One simple kinetic possibility is that ATP, but
not 3-OMFP, accelerates the transition between E2
and E1. Such a hypothesis would be in line with a
single Km displayed for 3-OMFP (Table 1). The re-
sultant increase in the relative fraction of enzyme in
the E2 conformation with 3-OMFP as substrate
could increase the apparent a⁄nity for Ca2 by
this conformer. To test this hypothesis we measured
the Ca2 dependence for ATP hydrolysis at low ATP
concentrations (5 WM) that are not able to accelerate
the E2CE1 transition. Irrespective of the ATP con-
centration used, no inhibition was observed between
50 and 500 WM Ca2 (Fig. 9), discarding this possi-
bility.
4. Discussion
Our data show that the substrate analogue 3-
OMFP binds and, in £agrant contrast with the
pNPPase activity, is hydrolyzed by both major con-
Fig. 9. Ca2 dependence for ATP hydrolysis at low and high
ATP concentrations. Enzyme was incubated in the standard
medium except that 3-OMFP was omitted and either 5 WM
[Q-32P]ATP (a) or 1 mM [Q-32P]ATP (b) was added. CaCl2 was
added to give the free Ca2 concentrations indicated. ATPase
activity was measured as described in Section 2. Values are the
means of two experiments with di¡erent preparations.
Fig. 8. 3-OMFP-supported Ca2 uptake by inside-out vesicles.
250 Wg ml31 of inside-out vesicles were incubated in a standard
medium containing 400 WM 3-OMFP, 4 Wg ml31 CaM, 0.2 mM
EGTA and CaCl2 to give 50 WM free Ca2. Ca2 uptake was
as described in Section 2. Values are the average þ S.E. of three
experiments with di¡erent preparations. a, result obtained after
addition of the Ca2 ionophore A23587.
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formers of PMCA. In the absence of Ca2 bound to
the enzyme, 3-OMFP is hydrolyzed exclusively by
E2, in an uncoupled hydrolytic cycle, with low veloc-
ity, by the nonactivated state of the enzyme
(E2:‘basal’). Activation by acidic phospholipids, by
controlled trypsinization, but not by calmodulin, ac-
celerate the hydrolytic rates (Figs. 1 and 3). Ca2
binding to the high a⁄nity sites at the enzyme trig-
gers a hydrolytic cycle coupled to the Ca2 transport,
putatively through the entire E1^E2 cycle (Fig. 8). At
this moment it is not clear whether the total velocity
measured after Ca2 binding is due solely to the
coupled cycle or if some uncoupled velocity persists
at this condition. An abrupt inhibition is observed at
Ca2 concentrations above 50 WM. Such inhibition
does not appear to be due to possible modi¢cations
of the equilibrium between E1 and E2 forms caused
by the substrate (Fig. 9). Precipitation of complexes
between 3-OMFP and Ca2, at concentrations higher
than 50 WM Ca2, was not observed. It may be that
the binding of 3-OMFP to its site and the binding of
Ca2 to the low a⁄nity Ca2 binding site can inter-
fere with each other.
In contrast with other P-type ATPases, only few
kinetic data are available for the characterization of
the hydrolytic cycle of PMCA. For the sake of sim-
plicity, a minimal reaction cycle has been adopted
[61^64] (Scheme 1), similar to the one previously
adopted for other closely related P-type ATPases
[65,66]. As previously observed, E1 has a high a⁄nity
Ca2 binding site facing the cytoplasmic surface, and
is phosphorylated by ATP, with high a⁄nity, in the
presence of calmodulin. E2 has a low a⁄nity Ca2
site facing the extracellular side, and is not phosphor-
ylated by ATP. This simplest scheme does not dis-
criminate possible random reactions of ATP and
Ca2 binding to E1 or E2, or possible binding of
ATP to the phosphorylated enzyme. The dependence
of the steady-state ATPase reaction rate on ATP
concentration for PMCA shows a hyperbolic behav-
ior in the absence of calmodulin or other activators,
and a nonhyperbolic behavior, with at least two Km
values for ATP, in their presence [42,67,68]. Such a
composed curve has also been observed for the
largely studied sarcoplasmic reticulum Ca2-ATPase
and (Na+K)-ATPase. The high a⁄nity Km for
ATP has been attributed to binding and phosphory-
lation at the catalytic site in the E1 conformation.
Recently, it has been pointed that ATP may bind,
with lower a⁄nity, to the catalytic Pi release site of
state E2, accelerating the rate of the steps that in-
volve interconversion of dephosphorylated enzyme
forms (step 5 in Scheme 1) [69^71]. It has also been
pointed out that ATP (and its analogue TNP-AMP)
can bind to the phosphorylated enzyme in the E2
state, accelerating the rate constant for Ca2 (or Pi)
release (step 4 in Scheme 1). It has not been unam-
biguously shown whether this last e¡ect is due to
ATP binding to a separate e¡ector site or, with low-
ered a⁄nity, to the active site [71^73].
Here we show unambiguously that, regarding
PMCA, ATP binds with both high and low a⁄nities
to the E2 conformation of the enzyme (Fig. 6), with
no need of interconversion between the conformers.
The high a⁄nity ATP binding site at the E2 confor-
mation is blocked by FITC covalently bound and,
thus, may correspond to ATP binding at the catalytic
site (Fig. 6B). Therefore, we can propose that ATP
binds to the catalytic site at the E1 and E2 conform-
ers with similar a⁄nities, and is hydrolyzed by E1
but not by E2. As a corollary, Ca2 binding to its
high a⁄nity site at the enzyme would not modify the
surroundings of the adenine-binding site, since the
a⁄nities were not modi¢ed, but would approach
the adenine binding domain to the aspartyl residue
at the phosphorylation domain. This is in line with
the recent crystal resolution of the sarcoplasmic re-
ticulum Ca2 pump, that shows that the nucleotide
and the phosphorylation domains lie more than 25 Aî
apart in the dephosphorylated state [74].
With FITC covalently bound to the catalytic site,
the enzyme remains able to bind and hydrolyze 3-
OMFP, a bulky ATP analogue, both by the E2 con-
former (pCa 9.0 in Figs. 4,5B and 6B) and by the
entire E1^E2 cycle (pCa 4.3 in Figs. 4 and 7). In the
last condition, as postulated for the P-type ATPases,
3-OMFP must be able to phosphorylate PMCA.
This site for 3-OMFP hydrolysis may either be a
separate and new catalytic site, at an aspartyl residue
other than Asp465, or, alternatively, a subsite of the
catalytic site that, in this case, must be big enough to
accommodate both substrate analogues (FITC and
3-OMFP) simultaneously. Although we can not dis-
criminate between the two hypotheses, the second
one appears to be more plausible. Since only one
Km was measured with 3-OMFP as substrate, there
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is no need to postulate more than one 3-OMFP bind-
ing site. This site binds and hydrolyzes pNPP in the
E2 state and binds (but does not hydrolyze) ATP
with low a⁄nity (Figs. 5 and 6). After changing to
the E1 conformation, this site looses the ability for
hydrolyzing pNPP, but maintains the ability for hy-
drolyzing 3-OMFP. This is an intriguing result and
may mean that this is a highly mobile site which
needs 3-OMFP (or, alternatively, ATP) in order to
position the enzyme residues for proper catalysis.
The minute amounts of enzyme found in the plas-
ma membranes have transformed the localization of
the enzyme and the measurement of its partial step
rates into a formidable task. Here we described a
highly sensitive and continuous £uorimetric assay
that, similarly to the observation with the cell cycle
regulator Cdc25b [26,75], may serve to quantitatively
measure rates of phosphorylation and dephosphory-
lation in real times and temperatures, using a fast
kinetic £uorimeter. The compound has the advantage
of binding to both E1 and E2 conformers and can
also be used, in the future, as a £uorimetric probe for
the ATP binding site at the conformation E2. It is
noticeable that, under optimal conditions, 3-OMFP
hydrolysis attained values comparable to those of
ATP hydrolysis by the enzyme.
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